PIN97 Achieving 2030 Unaids Goals in Human Immunodeficiency VIRUS Individuals: A Simulation MODEL to Prioritize Interventions for Decision Making

Pep Coll, Marisa Casado(Pharmacoeconomics and Health Outcomes Research Iberia (Spain)), Inmaculada Jarrín(Instituto de Salud Carlos III), Raquel Domínguez‐Hernández(Pharmacoeconomics and Health Outcomes Research Iberia (Spain)), José Manuel Martínez Sesmero, E Martínez(Hospital Clínic de Barcelona)

Value in Health

December 1, 2020

10.1016/j.jval.2020.08.938

Cited by 0

Related Papers

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

|The Lancet|2019|1k

Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies

|The Lancet HIV|2023|506

Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy

|Annals of Internal Medicine|2020|342

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

|Clinical Microbiology and Infection|2020|128

Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With Apples

|American Journal of Epidemiology|2019|116